Skip to main content
Oxford University Press - PMC COVID-19 Collection logoLink to Oxford University Press - PMC COVID-19 Collection
. 2022 Jun 9:dgac355. doi: 10.1210/clinem/dgac355

Impact of COVID-19 vaccines on thyroid function and autoimmunity and impact of thyroid autoimmunity on antibody response

David Tak Wai Lui 1,, Chi Ho Lee 2, Chloe Yu Yan Cheung 3, Jimmy Ho Cheung Mak 4, Carol Ho Yi Fong 5, Brian Wan Ching Lui 6, Venus Suet Ying Cheung 7, Wing Sun Chow 8, Alan Chun Hong Lee 9, Anthony Raymond Tam 10, Polly Pang 11, Tip Yin Ho 12, Kathryn Choon Beng Tan 13, Yu Cho Woo 14, Ivan Fan Ngai Hung 15, Karen Siu Ling Lam 16
PMCID: PMC9214146  PMID: 35679093

Abstract

Objectives

We evaluated impact of COVID-19 vaccination on thyroid function and antibodies, and influence of pre-existing thyroid autoimmunity on neutralizing antibody (NAb) responses.

Methods

Adults without history of COVID-19/thyroid disorders who received COVID-19 vaccination during June–August 2021 were recruited. All received two doses of vaccines. Thyroid-stimulating hormone (TSH), free thyroxine (fT4), free triiodothyronine (fT3), anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) antibodies were measured at baseline and 8 weeks post-vaccination. NAb against SARS-CoV-2 receptor-binding domain was measured.

Results

215 individuals were included (129[60%] BNT162b2; 86[40%] CoronaVac recipients): mean age 49.6 years, 37.2% men, and 12.1% anti-TPO/Tg positive at baseline. After vaccination, TSH did not change (p=0.225), but fT4 slightly increased (from 12.0±1.1 to 12.2±1.2pmol/L [from 0.93±0.09 to 0.95±0.09ng/dL], p<0.001) and fT3 slightly decreased (from 4.1±0.4 to 4.0±0.4pmol/L [from 2.67±0.26 to 2.60±0.26pg/mL], p<0.001). Only 3 patients (1.4%) had abnormal thyroid function post-vaccination, none clinically overt. Anti-TPO and anti-Tg titres increased modestly after vaccination (p<0.001), without significant changes in anti-TPO/Tg positivity. Changes in thyroid function and anti-thyroid antibodies were consistent between BNT162b2 and CoronaVac recipients, except for greater anti-TPO titre rise post-BNT162b2 (p<0.001). NAb responses were similar between individuals with and without pre-existing thyroid autoimmunity (p=0.855).

Conclusion

COVID-19 vaccination was associated with modest increase in anti-thyroid antibody titres. Anti-TPO increase was greater among BNT162b2 recipients. However, there was no clinically significant thyroid dysfunction post-vaccination. NAb responses were not influenced by pre-existing thyroid autoimmunity. Our results provided important reassurance for people to receive COVID-19 vaccination.

Keywords: COVID-19, SARS-CoV-2, vaccines, thyroid function tests, autoimmunity


Articles from The Journal of Clinical Endocrinology and Metabolism are provided here courtesy of Oxford University Press

RESOURCES